- Trials with a EudraCT protocol (7)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
7 result(s) found for: Steroid sulfate.
Displaying page 1 of 1.
EudraCT Number: 2022-003825-24 | Sponsor Protocol Number: 2059/2022 | Start Date*: 2024-03-15 |
Sponsor Name:Medical University of Vienna | ||
Full Title: Drug Concentration and degradation profiles of steroid and antibiotic eye drops in human aqueous humor. | ||
Medical condition: Postoperative inflammatory response - pharmakokinetics of steroids and antibiotics applied as eye drops | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2019-001540-22 | Sponsor Protocol Number: MD2019 | Start Date*: 2020-01-22 |
Sponsor Name:Abteilung für Hals- Nasen- Ohrenkrankheiten MUW, AKH Wien | ||
Full Title: Assessment of vertigo control rate following common treatments in Menière´s disease | ||
Medical condition: In our study we try to evaluate the the effect of common therapies in Menière´s disease patients on vertigo control calculation, Hydrops MRI, vHIT (video head impuls test) , caloric testing, audiol... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: AT (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2015-000538-31 | Sponsor Protocol Number: Neuroimpa2015 | Start Date*: 2015-06-01 | |||||||||||
Sponsor Name:Charité University medicine Berlin | |||||||||||||
Full Title: NEUORIMPA - Intraarticular Application of Opioids in Chronic Arthritis of the knee joint | |||||||||||||
Medical condition: chronic arthritis of the knee joint effusion as part of spondyloarthritis (Assessments in SpondyloArthritis international Society, ASAS criteria), Rheumatoid Arthritis, RA (according to American Co... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-001373-16 | Sponsor Protocol Number: CLIK066X2205 | Start Date*: 2017-09-04 | |||||||||||
Sponsor Name:Novartis Pharma AG | |||||||||||||
Full Title: A randomized, subject- and investigator-blinded, placebo-controlled pharmacodynamic study of oral LIK066 in overweight and obese women with polycystic ovary syndrome | |||||||||||||
Medical condition: polycystic ovary syndrome | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-001321-31 | Sponsor Protocol Number: 24032020 | Start Date*: 2020-04-11 |
Sponsor Name:Hospital Universitario de Fuenlabrada | ||
Full Title: Prospective, phase II, randomized, open-label, parallel group study to evaluate the efficacy of hydroxychloroquine together with baricitinib, imatinib or early lopinavir / ritonavir in patients wit... | ||
Medical condition: Pneumonia due to SARS Cov2 (COVID-19) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2012-001251-40 | Sponsor Protocol Number: MEA115588 | Start Date*: 2012-10-16 |
Sponsor Name:GlaxoSmithKline Research and Development Limited | ||
Full Title: MEA115588 A randomised, double-blind, double-dummy, placebo-controlled, parallel-group, multi-centre study of the efficacy and safety of mepolizumab adjunctive therapy in subjects with severe uncon... | ||
Medical condition: Subjects with severe, refractory, uncontrolled asthma with elevated blood eosinphils | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Completed) GB (Completed) DE (Completed) ES (Completed) IT (Completed) Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2021-006184-19 | Sponsor Protocol Number: SPI-62-CL-2001 | Start Date*: 2022-06-22 | |||||||||||
Sponsor Name:Sparrow Pharmaceuticals, Inc. | |||||||||||||
Full Title: SPI-62 as a Treatment for Adrenocorticotropic Hormone-dependent Cushing’s Syndrome | |||||||||||||
Medical condition: Cushing’s Syndrome | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: BG (Trial now transitioned) RO (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
